Authors:
Durbin, AP
Karron, RA
Sun, W
Vaughn, DW
Reynolds, MJ
Perreault, JR
Thumar, B
Men, R
Lai, CJ
Elkins, WR
Chanock, RM
Murphy, BR
Whitehead, SS
Citation: Ap. Durbin et al., Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region, AM J TROP M, 65(5), 2001, pp. 405-413
Citation: Ap. Durbin et al., African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1,-2, and-3 infection, VACCINE, 18(22), 2000, pp. 2462-2469
Authors:
Bailly, JE
McAuliffe, JM
Durbin, AP
Elkins, WR
Collins, PL
Murphy, BR
Citation: Je. Bailly et al., A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates, J VIROLOGY, 74(7), 2000, pp. 3188-3195
Authors:
Goldstein, S
Ourmanov, I
Brown, CR
Beer, BE
Elkins, WR
Plishka, R
Buckler-White, A
Hirsch, VM
Citation: S. Goldstein et al., Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus, J VIROLOGY, 74(24), 2000, pp. 11744-11753
Authors:
Schmidt, AC
McAuliffe, JM
Huang, A
Surman, SR
Bailly, JE
Elkins, WR
Collins, PL
Murphy, BR
Skiadopoulos, MH
Citation: Ac. Schmidt et al., Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates, J VIROLOGY, 74(19), 2000, pp. 8922-8929
Authors:
Teng, MN
Whitehead, SS
Bermingham, A
St Claire, M
Elkins, WR
Murphy, BR
Collins, PL
Citation: Mn. Teng et al., Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees, J VIROLOGY, 74(19), 2000, pp. 9317-9321
Authors:
Skiadopoulos, MH
Surman, SR
St Claire, M
Elkins, WR
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytialvirus cpts530 L polymerase mutation, VIROLOGY, 260(1), 1999, pp. 125-135
Authors:
Whitehead, SS
Bukreyev, A
Teng, MN
Firestone, CY
St Claire, M
Elkins, WR
Collins, PL
Murphy, BR
Citation: Ss. Whitehead et al., Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees, J VIROLOGY, 73(4), 1999, pp. 3438-3442
Authors:
Whitehead, SS
Firestone, CY
Karron, RA
Crowe, JE
Elkins, WR
Collins, PL
Murphy, BR
Citation: Ss. Whitehead et al., Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity, J VIROLOGY, 73(2), 1999, pp. 871-877
Authors:
Hirsch, VM
Campbell, BJ
Bailes, E
Goeken, R
Brown, C
Elkins, WR
Axthelm, M
Murphey-Corb, M
Sharp, PM
Citation: Vm. Hirsch et al., Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): Implications for the origins of SIVmndand other primate lentiviruses, J VIROLOGY, 73(2), 1999, pp. 1036-1045
Authors:
Whitehead, SS
Hill, MG
Firestone, CY
St Claire, M
Elkins, WR
Murphy, BR
Collins, PL
Citation: Ss. Whitehead et al., Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates, J VIROLOGY, 73(12), 1999, pp. 9773-9780
Authors:
Auwaerter, PG
Rota, PA
Elkins, WR
Adams, RJ
DeLozier, T
Shi, YQ
Bellini, WJ
Murphy, BR
Griffin, DE
Citation: Pg. Auwaerter et al., Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains, J INFEC DIS, 180(4), 1999, pp. 950-958
Authors:
Durbin, AP
Cho, CJ
Elkins, WR
Wyatt, LS
Moss, B
Murphy, BR
Citation: Ap. Durbin et al., Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies, J INFEC DIS, 179(6), 1999, pp. 1345-1351
Authors:
Hirsch, VM
Sharkey, ME
Brown, CR
Brichacek, B
Goldstein, S
Wakefield, J
Byrum, R
Elkins, WR
Hahn, BH
Lifson, JD
Stevenson, M
Citation: Vm. Hirsch et al., Vpx is required for dissemination and pathogenesis of SIVSM PBj: Evidence of macrophage-dependent viral amplification, NAT MED, 4(12), 1998, pp. 1401-1408